Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]
Wang HH, Lee HM, Raja V, et al. J Exp Pharmacol. 2019;11:1–14.On page 13 the disclosure section should be presented as follows:DisclosureLMG is listed as an inventor on several related patents and these have been fully assigned to his institution, Stony ...
Saved in:
Main Authors: | Wang HH (Author), Lee HM (Author), Raja V (Author), Hou W (Author), Iacono VJ (Author), Scaduto J (Author), Johnson F (Author), Golub LM (Author), Gu Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications
by: Wang HH, et al.
Published: (2019) -
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
by: Deng J, et al.
Published: (2020) -
A Novel Chemically-Modified Curcumin 2.24: Short-Term Systemic Therapy for Natural Periodontitis in Dogs
by: Jie Deng, et al.
Published: (2021) -
A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis
by: Deng J, et al.
Published: (2021) -
The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats
by: Bhatt HD, et al.
Published: (2022)